Sight is the most important one of our senses and has an increased importance in the information society we live in today. With a strong focus on research, Santen is dedicated to developing new and better methods and medicines for treating eye diseases. We have two research and development centers, one in Japan and one in Finland. Most of Santen’s products for the European and US markets are manufactured in Finland.
During the past decade, Santen has strengthened its position as a major ophthalmic pharmaceutical products supplier in Europe. Our biggest markets are Germany, Russia, Finland, Sweden, USA and Norway.
Santen will be one of the leading companies in the ophthalmic pharmaceutical field in Europe.
Key facts of Santen Europe
Pharmaceutical operations specializing in ophthalmics
Santen Finland, core business HQ
Santen Germany, strategic HQ
Turnover about 95 million €
One of the three R&D units
About 15 % of the turnover is used for R&D
Manufacturing plan in Finland supplying products for Europe, USA and Asia
Export to 30 countries
About 550 employees
Presence in 20 countries
Santen Finland
Core Operation HQ Function
Sales & Marketing
Research & Development
Manufacturing
Quality Control & Quality Assurance
Finance & Administration
Santen Germany
Strategic HQ Function
Corporate Planning
Business Development
Product Planning & Business Intelligence
Marketing Planning
SantenPharma AB, Solna, Sweden
Sales and Marketing in Sweden, Denmark, Norway and Iceland
